Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation

Lung cancer is a leading cause of cancer-related mortality across the world and tobacco smoking is the major risk factor. The Wnt signaling pathway is known to be involved in smoke-induced tumorigenesis in the lung. Promoter hypermethylation of Wnt inhibitory factor 1 (Wif1) has become a common event in a number of human tumors. Using a methylation-specific PCR, hypermethylation of the Wif1 gene promoter was evaluated in 139 primary nonsmall cell lung cancers (NSCLCs) and its correlation with clinicopathological and prognostic parameters was evaluated. Methylation of Wif1 was observed in 47.5% and 20.9% of neoplastic and adjacent normal lung tissues, respectively. Its methylation rate tended to be higher in stage I than stages II-IIIA. Results of Kaplan-Meier analysis showed no significant difference in overall survival according to Wif1 methylation status. However, Wif1 methylation showed an association with unfavorable prognosis of adenocarcinoma (AC) patients with EGFR mutation. According to our current findings, Wif1 promoter methylation is an early, frequent event as an epigenetic field manner and could be considered as a useful prognostic marker for AC patients with EGFR mutation. Further investigation into the therapeutic potential of this finding is warranted.

[1]  Dong Sun Kim,et al.  Hypermethylation of growth Arrest DNA-damage-inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features , 2010, Molecules and cells.

[2]  T. Goya,et al.  Clinico-Pathological and Biological Significance of Tyrosine Kinase Domain Gene Mutations and Overexpression of Epidermal Growth Factor Receptor for Lung Adenocarcinoma , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  J. Rubin,et al.  Secreted WNT antagonists as tumor suppressors: pro and con. , 2006, Frontiers in bioscience : a journal and virtual library.

[4]  Riccardo Ferracini,et al.  IL-7 Up-Regulates TNF-α-Dependent Osteoclastogenesis in Patients Affected by Solid Tumor , 2006, PloS one.

[5]  J. Herman,et al.  Promoter Hypermethylation of Resected Bronchial Margins , 2004, Clinical Cancer Research.

[6]  J. Herman,et al.  Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. , 2008, Carcinogenesis.

[7]  Dong Sun Kim,et al.  Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer , 2012, Molecules and cells.

[8]  F. Gilliland,et al.  Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. , 2002, Cancer research.

[9]  Y. Katayama,et al.  Effect of IFN-β on human glioma cell lines with temozolomide resistance , 2009 .

[10]  Qian Tao,et al.  Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers , 2009, Epigenetics.

[11]  M. Esteller,et al.  Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung , 2006, International journal of cancer.

[12]  Shuhang Wang,et al.  DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer , 2012, Journal of Experimental & Clinical Cancer Research.

[13]  H. Nakamura,et al.  Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis , 2005, Thorax.

[14]  S. Paul,et al.  Wnt signaling and cancer development: therapeutic implication. , 2008, Neoplasma.

[15]  Dong Sun Kim,et al.  Promoter methylation of Wnt antagonist DKK1 gene and prognostic value in Korean patients with non-small cell lung cancers. , 2012, Cancer biomarkers : section A of Disease markers.

[16]  Tianhui Hu,et al.  Convergence between Wnt-β-catenin and EGFR signaling in cancer , 2010, Molecular Cancer.

[17]  J. Samet,et al.  Smoking and Cancer Risk in Korean Men and Women , 2004, Cancer Causes & Control.

[18]  P. Laird,et al.  The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma , 2007, Disease markers.

[19]  C. H. Kim,et al.  Aberrant DNA methylation profiles of non-small cell lung cancers in a korean population , 2007 .

[20]  S. Davis,et al.  Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate , 2010, Oncogene.

[21]  R. Crystal,et al.  Down-Regulation of the Canonical Wnt β-Catenin Pathway in the Airway Epithelium of Healthy Smokers and Smokers with COPD , 2011, PloS one.

[22]  J. Minna,et al.  Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer , 2003, International journal of cancer.

[23]  Joachim Herz,et al.  Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? , 2004, Trends in molecular medicine.

[24]  Daniel A. Haber,et al.  Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.

[25]  J. Minna,et al.  DNA methylation profiles of lung tumors. , 2001, Molecular cancer therapeutics.

[26]  M. Gallup,et al.  Wnt and Hedgehog Are Critical Mediators of Cigarette Smoke-Induced Lung Cancer , 2006, PloS one.

[27]  J. Minna,et al.  Focus on lung cancer. , 2002, Cancer cell.

[28]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[29]  Biao He,et al.  Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer , 2004, Cancer Research.

[30]  Oliver Eickelberg,et al.  WNT signaling in lung disease: a failure or a regeneration signal? , 2010, American journal of respiratory cell and molecular biology.

[31]  I. Yoshino,et al.  Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers. , 2009, International journal of oncology.

[32]  M. Tennis,et al.  Wnt signaling pathway and lung disease. , 2008, Translational research : the journal of laboratory and clinical medicine.

[33]  Biao He,et al.  Wnt signaling in lung cancer. , 2005, Cancer letters.